Hopp til hovedinnhold

Stamcellebehandling (HSCT) ved MS

Sist oppdatert: Sist revidert:


  1. Burman J1, Iacobaeus E2, Svenningsson A3, Lycke J4, Gunnarsson M5, Nilsson P6, Vrethem M7, Fredrikson S8, Martin C9, Sandstedt A10, Uggla B11, Lenhoff S12, Johansson JE13, Isaksson C14, Hägglund H15, Carlson K15, Fagius J1.. Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience. J Neurol Neurosurg Psychiatry. 2014; Oct;85(10): 1116-21. pmid:24554104 PubMed  
  2. Radaelli M1, Merlini A, Greco R, Sangalli F, Comi G, Ciceri F, Martino G.. Autologous bone marrow transplantation for the treatment of multiple sclerosis. Curr Neurol Neurosci Rep. 2014. pmid:25037718 PubMed  
  3. Zhukovsky C, Sandgren S, Silfverberg T, Einarsdottir S, Tolf A, Landtblom AM, Novakova L, Axelsson M, Malmestrom C, Cherif H, Carlson K, Lycke J, Burman J. Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study. J Neurol Neurosurg Psychiatry. 2021 Feb;92(2):189-194. doi: 10.1136/jnnp-2020-323992. Epub 2020 Oct 26. PMID: 33106366 PubMed  
  4. Miller AE, Chitnis T, Cohen BA, Costello K, Sicotte NL, Stacom R; National Medical Advisory Committee of the National Multiple Sclerosis Society. Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society. JAMA Neurol. 2021 Feb 1;78(2):241-246. doi: 10.1001/jamaneurol.2020.4025. PMID: 33104165. PubMed  
  5. Boffa G, Massacesi L, Inglese M, Mariottini A, Capobianco M, Lucia M, Amato MP, Cottone S, Gualandi F, De Gobbi M, Greco R, Scimè R, Frau J, Zimatore GB, Bertolotto A, Comi G, Uccelli A, Signori A, Angelucci E, Innocenti C, Ciceri F, Repice AM, Sormani MP, Saccardi R, Mancardi G; Italian BMT-MS study group. Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. Neurology. 2021 Jan 20:10.1212/WNL.0000000000011461. doi: 10.1212/WNL.0000000000011461. Epub ahead of print. PMID: 33472915. PubMed  
  6. Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R; . Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.. JAMA Neurol. 2018. pmid:28241268 PubMed  
  7. Muraro PA, Martin R, Mancardi GL, Nicholas R, Sormani MP, Saccardi R.. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.. Nat Rev Neurol 2017. pmid:28621766 PubMed